← All diseases

Heart and blood vessel diseases

Brugada syndrome

An inherited disease that disturbs the heart's electrical system. Irregular and dangerous heart rhythms can occur. These rhythms can cause fainting; many people have no complaints at all.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

Orphanet has a guideline for emergency doctors for this disease (language: French, German, Italian, Portuguese). See on Orphanet

Prepare an emergency card

This page is translated from the Turkish original.

This disease is followed through the “Heart and blood vessel diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

The heart beats regularly thanks to electrical signals. These signals are carried by tiny channels in the heart cells. In Brugada syndrome, one of these channels does not work well. An irregular, fast rhythm can develop in the lower chambers of the heart. The structure of the heart is usually normal.

Which symptoms can occur?

Many people have no symptoms at all. Symptoms usually begin in adulthood and are more common in men.

  • Fainting
  • Palpitations, an irregular heartbeat
  • Shortness of breath
  • Seizure-like episodes
  • Symptoms appearing at rest or during sleep
  • Symptoms getting worse during an illness with fever

How is it diagnosed?

The diagnosis is based on a heart tracing (ECG), which shows a typical pattern. If needed, a medicine test that brings out this pattern is done under a doctor's supervision. The doctor asks about the family history. A genetic test may be done, but in many people no gene is found.

Treatment and care

There is no treatment yet that removes the disease. If the risk is high, a pacemaker-like device is placed under the skin of the chest. This device detects a dangerous rhythm and corrects the heartbeat. Some medicines and high fever can disturb the rhythm; the doctor gives guidance about these. People without symptoms are followed regularly. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is usually passed on through dominant inheritance. A single changed gene is enough. For each child of an affected parent, the chance of passing it on is 1 in 2. Sometimes the change appears for the first time in the person. Genetic counselling guides the family.

Source: MedlinePlus Genetics: Brugada syndrome · NORD: Brugada syndrome

Key facts

When does it usually start?
Adulthood, Childhood
Gene(s) involved
SCN5A

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Brugada

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

Questions you can ask your doctor

  • Could this trial be suitable for us?
  • If we take part, how would current treatment and check-ups be affected?
  • Where does the trial take place, and how are travel and accommodation handled?
  • What happens if we want to leave the trial?

ClinicalTrials.gov lists 3 active interventional studies for this disease. 1 is recruiting now; none has a site in Türkiye. Last checked: October 7, 2026.

Selected records (studies with a site in Türkiye first):

See all studies on ClinicalTrials.gov · Joining clinical trials

Heart and blood vessel diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:130 · ICD-11 BC65.1

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.